Skip to content

Syncor Pharmaceuticals, Inc.

United StatesFDA 510(k) applicant, unverified

Devices
4

What Syncor Pharmaceuticals, Inc. makes

Syncor Pharmaceuticals, Inc. manufactures PharmaSeed devices, including models BT-103-1, BT-103-3, BT-125-3, and BT-125-1, which are designed for pharmaceutical applications.

These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue4

Newest first, rows 1-4 of 4

Frequently asked questions

How many devices does Syncor Pharmaceuticals, Inc. have in the registry?

The registry currently lists 4 devices for Syncor Pharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Syncor Pharmaceuticals, Inc.'s devices?

Among its 4 most recently registered devices, Syncor Pharmaceuticals, Inc. has devices listed in FDA 510(k) (4 devices).

What risk classes do Syncor Pharmaceuticals, Inc.'s devices fall under?

Among its 4 most recently registered devices, the classes recorded for Syncor Pharmaceuticals, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Syncor Pharmaceuticals, Inc. in the registry?

The most recently registered devices listed for Syncor Pharmaceuticals, Inc. include PHARMASEED, MODEL BT-103-1, PHARMASEED, MODEL BT-103-3, PHARMASEED, MODEL BT-125-3 and PHARMASEED, MODEL BT-125-1.

Generated automatically from registry data and not verified by a human reviewer.